• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

DDI Webinar - Safe Use Initiative, Collaborating to Reduce Preventable Harm.– March 24, 2014

 

The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) is again delighted to present a series of educational webinars targeting the needs of all Healthcare Professionals, Pharmacy students, Nurse Practitioner students, Physician Assistant and Medical students. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation.
 
These focused webinars support FDA's mission of promoting and protecting public health, through interaction and education to strengthen relationships with future clinicians, researchers, nurses, and pharmacists. Fostering this connection will provide a better understanding of FDA's role in public health as a regulatory agency.
 
On March 24, 2014, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar entitled, “Safe Use Initiative, Collaborating to Reduce Preventable Harm.” The featured speaker was John Whyte, MD, MPH, Director of Professional Affairs and Stakeholder Engagement (PASE), who gave an overview of the Safe Use Initiative: what it is, how its responsibility for managing drug risks differs from other CDER components, and what criteria it uses for deciding upon ongoing partnerships and activities. Dr. Whyte provided a few examples of the work Safe Use has become involved in since November 2009.
-

Presentation Information

-
If you've never used Connect Pro, get a quick overview: http://www.adobe.com/go/connectpro_overview
 
Adobe, the Adobe logo, Acrobat and Acrobat Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.